Bank of America’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-500
Closed -$94 8545
2024
Q1
$94 Sell
500
-301
-38% -$60 ﹤0.01% 7405
2023
Q4
$160 Buy
801
+101
+14% +$40 ﹤0.01% 7369
2023
Q3
$487 Buy
700
+200
+40% +$130 ﹤0.01% 7317
2023
Q2
$444 Sell
500
-745
-60% -$632 ﹤0.01% 7329
2023
Q1
$939 Buy
1,245
+660
+113% +$861 ﹤0.01% 7313
2022
Q4
$672 Sell
585
-156
-21% -$129 ﹤0.01% 7398
2022
Q3
$0 Buy
741
+1
+0.1% +$1 ﹤0.01% 8323
2022
Q2
$1K Sell
740
-9,291
-93% -$7.97K ﹤0.01% 7911
2022
Q1
$14K Sell
10,031
-6,755
-40% -$14.4K ﹤0.01% 7647
2021
Q4
$57K Buy
16,786
+3,071
+22% +$17.3K ﹤0.01% 7156
2021
Q3
$121K Sell
13,715
-5,382
-28% -$70.8K ﹤0.01% 6618
2021
Q2
$324K Sell
19,097
-18,771
-50% -$275K ﹤0.01% 5750
2021
Q1
$507K Buy
37,868
+21,403
+130% +$482K ﹤0.01% 5354
2020
Q4
$474K Buy
16,465
+13,091
+388% +$354K ﹤0.01% 5047
2020
Q3
$101K Buy
+3,374
New +$102K ﹤0.01% 5702

Other funds holding AFIB

Bank of America's AFIB Position: Q2 2024 in Review

Bank of America sold out of Acutus Medical Inc (AFIB) in Q2 2024, closing a stake of 500 shares — an estimated $94 sold.

Bank of America first reported a position in AFIB in Q3 2020 and held it in 15 quarters. The position peaked at $507K in Q1 2021. 1 fund tracked by Wall St. Rank holds AFIB as of Q2 2024.

  • Bank of America reported no remaining Acutus Medical Inc position as of Q2 2024 after selling out during the quarter.
  • Bank of America sold 500 Acutus Medical Inc shares in Q2 2024, an estimated $94.
  • Bank of America first reported a position in Acutus Medical Inc in Q3 2020 and held it in 15 quarters.
  • Bank of America's Acutus Medical Inc position peaked at $507K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2024.

Based on Bank of America's 13F filing for Q2 2024, filed 14 Aug 2024.